Screen for Life (SFL)

9/3/2017

​Enhanced Screen for Life (SFL) subsidies  (with effect from 1 September 2017) 

To encourage more Singaporeans to go for screening and follow-up, MOH and HPB will enhance SFL with effect from 1 September 2017. The enhanced framework described below will replace the current CHAS subsidy for health screening.
 
a) Subsidised health screening for all eligible Singaporeans at CHAS GP clinics, including those who do not have a CHAS or Pioneer Generation (PG) card
 
b) Low fixed patient co-payment for SFL screening and one post-screening consultation (if required)
i.              No charge for PG cardholders ;
ii.             $2 for CHAS cardholders; and
iii.            $5 for all other Singaporeans.
 
c) New GP remuneration framework for screening and one post-screening consultation (if required)

In line with MOH’s vision for “One Singaporean, One Family Doctor”, and to make screening and follow-up accessible to Singaporeans, all CHAS GP clinics are required to offer SFL subsidies with effect from 1 September 2017. We believe this will support the shift towards primary care leading screening and anchoring chronic disease management in the community. 

MOH will also launch the online Diabetes Risk Assessment (DRA) tool on 1 September 2017 as part of the efforts to go upstream in preventing diabetes. As part of a three-year pilot, the enhanced SFL subsidies for cardiovascular screening will be extended to individuals aged 18 – 39 years old who have been assessed to be ‘at risk’ of diabetes via the DRA

Enhanced Screen for Life (SFL) Resources * (Please click on the title to view and download the resources) 


Screen for Life (SFL) forms 

  *Please log in to Primary Care Pages to view the information    

Clinics can continue to use the existing registration form by following the steps below but do remind patients to enclose the form with their FIT specimen when mailing it out.


Useful Contacts to support clinic in administering SFL 
  •  For SFL related enquiries for clinics: Agency for Integrated Care 
Tel: 6632 1199; Email: gp@CHAS.sg
  •  For assistance and support, please contact your CHAS account manager in your CDC zone. 
Click here to find your CDC zone via the clinic’s postal code

Click here* for the contact list to contact the respective account manager.

   For HPB’s lifestyle follow-up programmes related enquiries: 
- Take Charge - Tel: 1800 223 13131800 223 1313
- Diabetes Prevention Programme - Email: HPB_nurse_educator@hpb.gov.sg 
  •  Appointed laboratories:  

- Parkway Laboratory Services (for cardiovascular risk, cervical cancer and colorectal cancer screening) 

Tel: 6278 9188; Email: enquiries_pls@parkway.com.sg; 
Opening Hours: Monday-Friday (8am to 4.30pm) and Saturday (8am to 12.30pm), excluding public holidays

How to Contact Parkway Lab:  

a. During office hours: Parkway can be contacted through Chatbox via www.parkwaylab.com.sq, WhatsApp: 9710 4015 or Hotline: 6278 9188. 

b. (NEW) An afterhours specimen collection hotline, 8331-2942 by Parkway Lab is now available for clinics to call if there are any collection issues.  It will be operational from Monday, 22 Jan 2018 and the timings are 5pm to 7pm (Mon-Fri) and 12.30pm to 2.30pm (Sat). 

The number will not be available on Sundays and Public Holidays. This is strictly for collections requested before Parkway’s stipulated closing time of 5pm (Mon-Fri) and 12.30pm (Sat).

 
 
 
  • BioMedix c/o Quest Laboratories (for colorectal cancer screening) 
Tel: 9101 0340; Email: customer_service@biomedix.com.sg; 
Opening Hours: Monday-Friday (9am to 6pm), excluding public holidays
  • For public enquiries and feedback: 

Please direct patients to call HPB HealthLine at 1800 223 13131800 223 1313, visit http://screenforlife.sg or www.hpb.gov.sg

Our Partners

  • Partner
  • Partner
  • Partner
  • Partner
  • Partner
Contact Us

No. 5 Maxwell Road, #10-00 Tower Block, MND Complex, Singapore 069110
GP Helpline: +65 6632 1199 | Email: gp@aic.sg

Connect with us
A portal by:

AIC


Copyright © 2019 Agency for Integrated Care. All Rights Reserved.